ASARM mineralization hypothesis: A bridge too far?

doi:10.1002/jbmr.69

Commentary

You have free access to this content

ASARM mineralization hypothesis: A bridge too far?^†

Valentin David,
L Darryl Quarles^*

Article first published online: 23 FEB 2010

DOI: 10.1002/jbmr.69

Issue

Journal of Bone and Mineral Research

Volume 25, Issue 4, pages 692–694, April 2010

Additional Information

How to Cite

David, V. and Quarles, L. D. (2010), ASARM mineralization hypothesis: A bridge too far?. Journal of Bone and Mineral Research, 25: 692–694. doi: 10.1002/jbmr.69

Author Information

Department of Medicine, Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA

Email: L Darryl Quarles (dquarles@uthsc.edu)

^*UTMG Endowed Professor, Department of Medicine, Division of Nephrology, University of Tennessee Health Science Center, 956 Court Ave, Suite B226, Memphis, TN 38163, USA.

^†
William N Addison and Marc D McKee have subsequently responded with a Letter to the Editor available here: http://dx.doi.org/10.1002/jbmr.110.

Publication History

Issue published online: 9 APR 2010
Article first published online: 23 FEB 2010
Accepted manuscript online: 23 FEB 2010 12:00AM EST

ARTICLE TOOLS

View Full Article (HTML) Get PDF (58K)

References

1
Liu S, Tang W, Zhou J, et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006; 17: 1305–1315.
2
Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281: 6120–6123.
3
Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444: 770–774.
4
Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008; 118: 3820–3828.
5
Quarles LD. Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest. 2003; 112: 642–646.
6
Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006; 38: 1310–1315.
7
Rowe PS, Kumagai Y, Gutierrez G, et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone. 2004; 34: 303–319.
8
Liu S, Rowe PS, Vierthaler L, Zhou J, Quarles LD. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. J Endocrinol. 2007; 192: 261–267.
9
Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006; 291: E38–E49.
10
Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006; 1310–1315.
11
Guo R, Rowe PS, Liu S, Simpson LG, Xiao ZS, Quarles LD. Inhibition of MEPE cleavage by Phex. Biochem Biophys Res Commun. 2002; 297: 38–45.
12
Rowe PS, Garrett IR, Schwarz PM, et al. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone. 2005; 36: 33–46.
13
Addison W, Masica D, Gray J, McKee MD. Phosphorylation-Dependent Inhibition of Mineralization by Osteopontin ASARM Peptides is Regulated by PHEX Cleavage. J Bone Miner Res. 2009;
Direct Link:
14
Xiao ZS, Crenshaw M, Guo R, Nesbitt T, Drezner MK, Quarles LD. Intrinsic mineralization defect in Hyp mouse osteoblasts. Am J Physiol. 1998; 275: E700–E708.
15
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res. 2008; 23: 1638–1649.
Direct Link:
16
Martin A, David V, Laurence JS, et al. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology. 2008; 149: 1757–1772.
17
Rivadeneira F, Styrkarsdottir U, Estrada K, et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41: 1199–1206.
18
Liu S, Brown TA, Zhou J, et al. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol. 2005; 16: 1645–1653.
19
Yuan B, Takaiwa M, Clemens TL, et al. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest. 2008; 118: 722–734.
20
Yuan B, Feng JQ, Xing Y, Meudt J, Rowe PS, Drezner MK. Aberrant Phex Function in Osteocytes Has Limited Effects on Bone Mineralization in X-Linked Hypophosphatemia (XLH). J Bone Miner Res. 2008; 23.
21
David V, Martin A, Hedge AM, Rowe PS. Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology. 2009; 150: 4012–4023.
22
Rittling SR, Matsumoto HN, McKee MD, et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res. 1998; 13: 1101–1111.
Direct Link:
23
Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. 1998; 101: 1468–1478.
24
Yoshitake H, Rittling SR, Denhardt DT, Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A. 1999; 96: 8156–8160.
25
Boskey AL, Chiang P, Fermanis A, et al. MEPE's diverse effects on mineralization. Calcif Tissue Int. 2009; 86: 42–46.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
26
Rifas L, Cheng S, Halstead LR, Gupta A, Hruska KA, Avioli LV. Skeletal casein kinase activity defect in the HYP mouse. Calcif Tissue Int. 1997; 61: 256–259.

View Full Article (HTML) Get PDF (58K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

ASARM mineralization hypothesis: A bridge too far?^†

Journal of Bone and Mineral Research

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

ASARM mineralization hypothesis: A bridge too far?†

Journal of Bone and Mineral Research

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this

ASARM mineralization hypothesis: A bridge too far?^†